By: David Miller, BSc, N.D., NHP Scientific Regulatory Associate February 21, 2011 The recent revisions to the status of Levocarnitine in the Canadian regulatory environment (http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/html/sor-dors275-eng.html) have Read More >>
Schedule F Revisions Published The long-awaited Schedule F revisions have been published in Canada Gazette II. Amendments to the Food and Drug Regulations have been made to 10 naturally sourced […] Read More >>
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.